We recently characterized a gene-terpene network that is associated with artemisinin biosynthesis in selfpollinated (SP) Artemisia annua, an effective antimalarial plant. We hypothesize that an alteration of gene expression in the network may improve the production of artemisinin and its precursors. In this study, we cloned an isopentenyl pyrophosphate isomerase (IPPI) cDNA, AaIPPI1, from Artemisia annua (Aa). The fulllength cDNA encodes a type-I IPPI containing a plastid transit peptide (PTP) at its amino terminus. After the removal of the PTP, the recombinant truncated AaIPPI1 isomerized isopentenyl pyrophosphate (IPP) to dimethyl allyl pyrophosphate (DMAPP) and vice versa. The steady-state equilibrium ratio of IPP/DMAPP in the enzymatic reactions was approximately 1:7. The truncated AaIPPI1 was overexpressed in the cytosol of the SP A. annua variety. The leaves of transgenic plants produced approximately 4% arteannuin B (g g À1 , dry weight, dw) and 0.17-0.25% artemisinin (g g À1 , dw), the levels of which were significantly higher than those in the leaves of wild-type plants. In addition, transgenic plants showed an increase in artemisinic acid production of more than 1% (g g À1 , dw). In contrast, isoprene formation was significantly reduced in transgenic plants. These results provide evidence that overexpression of AaIPPI1 in the cytosol can lead to metabolic alterations of terpenoid biosynthesis, and show that these transgenic plants have the potential to yield high production levels of arteannuin B as a new precursor source for artemisinin.
INTRODUCTION
Isopentenyl pyrophosphate isomerase (IPPI, also called isopentenyl diphosphate isomerase, IDPI) catalyzes the interconversion of isopentenyl pyrophosphate (IPP, or isopentenyl diphosphate, IDP) and dimethylallyl pyrophosphate (DMAPP, or dimethylallyl diphosphate, DMADP) (Ramos-Valdivia et al., 1997; Oh et al., 2000; Berthelot et al., 2012; Zhou et al., 2013) . IPPI is classified into types I and II according to the cofactors required for its catalytic activity. Catalysis by type-I IPPI, which is found in animals, fungi, some bacteria and plants, requires Mg 2+ and zinc cofactors (Carrigan and Poulter, 2003; Lee and Poulter, 2006) . Catalysis by type-II IPPI, a flavoprotein found in archaea and some bacteria, requires the reduced form of flavin mononucleotide and Mg 2+ (Kaneda et al., 2001; Sharma et al., 2010) . In all plants investigated to date, type I has been found to be the form of the enzyme that maintains the steady-state levels of IPP and DMAPP (Figure 1a ) (Albrecht and Sandmann, 1994; Kajiwara et al., 1997; Gallagher et al., 2003; Phillips et al., 2008) . Over the past 10 years, fundamental progress has been achieved in localizing IPPI in the cytosol, plastids, mitochondria and peroxisomes (Okada et al., 2008; Phillips et al., 2008; Sapir-Mir et al., 2008; Vranova et al., 2013) . These studies have shown that plant cells employ a complicated metabolic compartmentalization of isoprenoids. Numerous studies have also shown that the formation of DMAPP in the cytosol and in plastids occurs through different enzymatic mechanisms. The MVA pathway has been demonstrated to produce IPP only ( Figure 1a ) (Hoeffler et al., 2002) ; thus, DMAPP in the cytosol of plants results from the isomerization of IPP catalyzed by a type-I IPPI. In plastids, in addition to the main production of DMAPP via IPP isomerization, recent reports have shown that 4-hydroxy-3-methyl-but-2-enyl pyrophosphate reductase (HDR) (Figure 1a) in the methylerythritol phosphate (MEP) pathway converts 4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) to both IPP and DMAPP at a steady-state ratio of approximately 6:1 (Rohdich et al., 2003; Brandt et al., 2004; Eisenreich et al., 2004) . Given that DMAPP is the primary starter C5 molecule (Figure 1a ), its pool size affects the biosynthesis of all downstream isoprenoids in plants, including the isoprene, monoterpenes (C10) and diterpenes (C20) synthesized in plastids, and the sesquiterpenes and triterpenes synthesized in the cytosol (Croteau et al., 2000; Okada et al., 2008; Phillips et al., 2008) . Therefore, IPPI activity and the IPP/DMAPP ratio play essential roles in the regulation of plant terpenoid metabolism. Artemisia annua produces artemisinin, an effective antimalarial endoperoxide sesquiterpene lactone (Liu et al., 1979; Klayman, 1985; Miller and Su, 2011) . Artemisinin- Figure 1 . Biosynthetic pathway of artemisinin and the metabolic network characterized in Artemisia annua. (a) Schematic diagram showing the pathways to artemisinin and other compounds, starting from the mevalonate and 2-C-methyl-D-erythritol 4-phosphate (MEP) pathways in A. annua. Metabolite abbreviations: DMAPP, dimethylallyl pyrophosphate; FPP, farnesyl pyrophosphate; G3P, glycerol-3-phosphate; GGPP, geranylgeranyl pyrophosphate; GPP, geranyl pyrophosphate; HMBPP, 4-hydroxy-3-methyl-but-2-enyl pyrophosphate; IPP, isopentyl pyrophosphate; and MVAPP, mevalonate pyrophosphate. Enzyme abbreviations: ADH1, alcohol dehydrogenase 1; ALDH1, aldehyde dehydrogenase; ADS, armorpha-4,11-diene synthase; CPR1, cytochrome P450 reductase 1; CYB5, cytochrome b5 monooxygenase; CYP71AV1, cytochrome P450 monooxygenase; DBR2, artemisinic aldehyde delta-11(13)-double bond reductase; HDR, 4-hydroxy-3-methyl-but-2-enyl pyrophosphate reductase (the wide arrow extending from HMBPP to IPP indicates HDR activity that is preferential for IPP); IPPI, isopentenyl diphosphate isomerase; MPDC, mevalonate 5-pyrophosphate decarboxylase. Question mark (?) indicates unknown. (b) A gene-metabolite network established from six tissues showing a metabolic association between AaIPPI1 and four artemisinin pathway genes (ADS, CYP71AV1, CPR1 and DBR2) and artemisinic acid (aa) and arteannuin B (a-b) (Ma et al., 2015) . based combination therapy (ACT) is the first-line treatment for malaria and saves the lives of millions of patients yearly (WHO, 2006 , 2010 , Ansari et al., 2013 , Taylor, 2013 . A. annua is a diploid cross-hybridized species (Delabays et al., 1993; Xie et al., 1995; Graham et al., 2010; AlejosGonzalez et al., 2011) that contains nine pairs of chromosomes. Over the past three decades, numerous breeding studies have been undertaken to create multiple hybrid cultivars of this species (Delabays et al., 1993 (Delabays et al., , 2001 Graham et al., 2010; Paul et al., 2014) , many of which have reported an increase in the production of artemisinin. The yield of artemisinin from hybrid cultivars does not yet meet the demand for ACT, however (Paddon et al., 2013) . In addition, the price of artemisinin has been unstable, and the cost of therapy is high for patients from countries in which malaria is endemic (White, 2008; Shretta and Yadav, 2012; Weathers and Towler, 2014) .
The use of artemisinin precursors from A. annua for in vitro semi-synthesis has recently emerged as an efficient alternative approach to the production of artemisinin (Paddon et al., 2013) . Over the past 10 years, artemisinic acid ( Figure 1a ) has been the main synthetic precursor used in the metabolic engineering of artemisinin. The biosynthetic pathway from armorpha-4,11-diene to artemisinic acid and dihydroartemisinic acid has been biochemically characterized by research efforts in enzyme analysis, gene cloning and synthetic approaches (Bouwmeester et al., 1999; Chang et al., 2000; Ro et al., 2006; Teoh et al., 2006) . As a significant result, the recent success of the synthetic biology of artemisinic acid coupled with the semi-synthesis of artemisinin has led to the industrial-scale production of these compounds to supplement ACT (Ro et al., 2006; Teoh et al., 2006; Paddon et al., 2013; Turconi et al., 2014) , although the cost of this synthetic technology remains to be improved (Peplow, 2016) . As is well understood, A. annua also produces arteannuin B and a wide array of diverse terpenoids (Figure 1a; Brown, 2010; Ma et al., 2015) . Chemical synthesis has demonstrated that arteannuin B is another appropriate precursor molecule for the semi-synthesis of artemisinin (Nowak and Lansbury, 1998) , and for biotransformation to artemisinin (Akhila et al., 1987; Nair and Basile, 1993; Dhingra and Lakshmi Narasu, 2001 ). These studies have demonstrated that the availability of a rich arteannuin B source may offer a new route to the production of sufficient artemisinin for the treatment of malaria.
To innovate new approaches to the increase in artemisinin production, we recently developed a self-pollinated (SP) variety of A. annua that produces artemisinin, artemisinic acid and arteannuin B (Alejos-Gonzalez et al., 2011) . In addition, the SP plants are capable of regeneration via both organogenesis and somatic embryogenesis from plant tissue culture (Alejos-Gonzalez et al., 2013; Ma et al., 2015) , and are highly transformable for genetic modification. Furthermore, an integrative metabolomics and transcriptomic study of A. annua, which characterized its gene-to-terpene landscape, showed that the biosynthesis of artemisinin and artemisinic acid is closely associated with the plant's development from the juvenile to the flowering phase. Unlike the content of artemisinin and artemisinic acid, which is highly dependent upon the spatial position and development of the plant, the content of arteannuin B is approximately 0.7-1.3% g g À1 dry weight
(dw) in all tissues analyzed, including the leaves of young seedlings as well as later flowers (Ma et al., 2015) . These superior properties allow the development of a new platform of SP plants to improve the production of artemisinin and its precursors. In addition, Weather et al. recently demonstrated that dried leaf products (such as leaf tablets) are an effective and inexpensive therapy for the treatment of malaria (Weathers and Towler, 2014; Weathers et al., 2014a,b) . Based on these discoveries, our SP plants may provide a new resource for the development of leaf products for the treatment of malaria.
Recently, we characterized a gene-terpene network that controls artemisinin biosynthesis in SP A. annua (Ma et al., 2015) . An uncharacterized IPPI homolog (namely, AaIPPI1) together with ADS, CYP71AV1, DBR2 and CPR1 is located in the network (Figure 1b) . We hypothesize that an overexpression of this AaIPPI1 may increase artemisinin biosynthesis in plants. In this study, an AaIPPI1 cDNA was cloned from A. annua. Sequence analysis of AaIPPI1 showed that it encodes a type-I IPPI. A recombinant truncated AaIPPI1, (-tp)AaIPPI1, was purified for enzymatic analysis. The (-tp) AaIPPI1 catalyzed the reversible isomerization of IPP and DMAPP at a final steady-state equilibrium ratio of approximately 1:7. GFP fusion and confocal microscopic analysis further demonstrated that the truncated (-tp)AaIPPI1 cDNA fragment encodes an enzyme that is localized in the cytosol. The (-tp)AaIPPI1 cDNA fragment was overexpressed to increase the level of the enzyme in transgenic self-pollinated A. annua plants. Metabolic analysis showed that transgenic plants yielded approximately 4% arteannuin B (g g À1 , dw), and that they contained significantly increased levels of artemisinin. In addition, isoprene formation was significantly reduced in the transgenic plants. This study provides evidence showing that overexpression of genes in the network can fundamentally increase the production of artemisinin and its precursors. In addition, AaIPPI1 transgenic plants could supply a new resource to produce arteannuin B for artemisinin synthesis.
RESULTS
Isolation of AaIPPI1 cDNA, sequence characterization and enzymatic activity An expressed sequence tag (EST) fragment was obtained from a glandular trichome cDNA library (Ma et al., 2009 Figure S1 ). We named this cDNA AaIPPI1 (Figure 1b ). An alignment with the amino acid sequences of seven IPPI homologs revealed that the first 59 N-terminal amino acids of AaIPPI1 did not align with four other reported homologs ( Figure S1 ). Further analysis using TARGETP (Emanuelsson et al., 2007) indicated that these 59 amino acids formed a plastid transit peptide (PTP) encoded by the 5 0 end of the ORF. Moreover, the alignment showed that the amino acid sequence of AaIPPI1 contained a conserved cysteine residue in a TNTCCSHPL motif and a conserved glutamate residue in a WGEHELDY motif, which are typical properties of the type-I IPPI family (Hahn et al., 1999) . Thus, AaIPPI1 is a member of the type-I IPPI family. Gene expression profiling showed that AaIPPI1 was expressed in five tissues, with relatively high expression levels in trichomes, leaves and flowers (Figure 2a, b) .
The full-length ORF of the AaIPPI1 cDNA, (tp)AaIPPI1, was cloned into a pET30a(+) vector ( Figure S2a ) and used to express a recombinant protein in Escherichia coli. After lysis of E. coli, however, the resulting recombinant protein, (tp)AaIPPI1, was found only in the inclusion bodies, and was not detected in the extraction buffer ( Figure S2b) . To obtain soluble protein, the first 177 nucleotides, which encode the first 59 amino acids forming the PTP, were removed from the 5 0 end of the ORF cDNA to produce a truncated cDNA fragment, (-tp)AaIPPI1. When the (-tp) AaIPPI1 cDNA fragment was introduced into the pET30a(+) vector ( Figure S2a) , expression of the construct in E. coli yielded a soluble protein in the extraction buffer. This protein was further purified ( Figure S2c ) for the enzyme assays.
An enzyme assay of the recombinant (-tp)AaIPPI1 was performed using IPP and DMAPP, two allylic prenyl diphosphate compounds, as substrates. Under alkaline phosphatase conditions, IPP and DMAPP are readily converted into 3-methyl-3-buten-1-ol (isoprenol) and 3-methyl-2-buten-1-ol, respectively (Ramos-Valdivia et al., 1997; Hoshino et al., 2006) . These two alcohol compounds can be easily measured by GC and GC-MS analysis alone; therefore, the activity of (-tp)AaIPPI1 was measured using these two alcohol compounds. After incubation of IPP with recombinant (-tp)AaIPP1, the steady-state equilibrium products of isomerization included IPP and DMAPP, which were converted to their corresponding isoprenol and 3-methyl-2-buten-1-ol, respectively (Figure 3a, b) . Measurement of the levels of isoprenol and 3-methyl-2-buten-1-ol showed that their final steady-state ratio was approximately 1:7 (Figure 3a ), indicating that approximately 87.5% of the IPP was isomerized to DMAPP. After incubation of DMAPP with recombinant (-tp)AaIPP1, the final steadystate equilibrium products of the isomerization reactions also included IPP and DMAPP, which were converted to their corresponding isoprenol and 3-methyl-2-buten-1-ol, respectively ( Figure 3b ). The ratio of isoprenol to 3-methyl-2-buten-1-ol was also approximately 1:7 (Figure 3b ), indicating that 12.5% of the DMAPP substrate was isomerized to IPP. Similar results were obtained after multiple repetitions of the enzymatic assay using various reaction times (e.g. 1 and 2 h) and substrate concentrations ( Figure S3 ). These results demonstrated that the recombinant (-tp) AaIPPI1 catalyzed the interconversion of IPP and DMAPP, reaching a final steady-state equilibrium ratio of approximately 1:7. In addition to phosphatase, hydrochloric acid (1 N) was used to dephosphorylate IPP and DMAPP isomerized by recombinant (-tp)AaIPPI1. The resulting data support the ratio of approximately 1:7 of IPP to DMAPP ( 
Cytosolic localization of (-tp)AaIPPI1
The cytosolic localization of (-tp)AaIPPI1 was analyzed by confocal microscopy. After removal of its stop codon (TAA), the resulting (-tp)AaIPPI1 was adjacently fused with the ATG of an EGFP in the pSITEII-EGFP-N1 binary vector to obtain a new binary plasmid, pSITEII-(-tp)AaIPPI1-EGFP ( Figure 4a ). This vector was introduced into Nicotiana benthamiana for transient expression. Observation of infected plants by confocal microscopy showed that the fused (-tp) IPPI1-EGFP protein was localized to the cytosol ( Figure 4a ).
Overexpression of (-tp)AaIPPI1 in self-pollinated A. annua
The (-tp)AaIPPI1 cDNA with its stop codon (TAA) was introduced into another binary vector, PMDC84. In the resulting recombinant binary plasmid, PMDC84-(-tp) AaIPPI1 (Figure 4b ), (-tp)AaIPPI1 was driven by a 2 9 35S
promoter but was not fused to GFP protein ( Figure 4b ). The binary vector PMDC84-(-tp)AaIPPI1 was introduced into self-pollinated A. annua. Multiple transgenic plants were obtained from genetic transformation. Among these, three lines, namely, OE-T1, OE-T15 and OE-T17 (Figure 4b ), were selected for further transgene expression analysis. Both semi-quantitative RT-PCR and qRT-PCR analyses using gene-specific primers (Table S1 ) revealed the expression of AaIPPI1 in both wild-type and transgenic plants ( Figure 4c ). The expression level of AaIPPI1 was much higher in transgenic plants than in wild-type plants (Figure 4c ), which indicated that the overexpression of the (-tp)AaIPPI1 transgene increased the level of AaIPPI1 messenger RNA. Western blot analysis using an AaIPPI1 antibody further showed that the level of AaIPPI1 was much higher in transgenic than in wild-type plants ( Figure S2d ). This result demonstrated that overexpression of the (-tp) AaIPPI1 transgene significantly increased the total content of AaIPPI1 protein in transgenic plants ( Figure S2d ). As shown in Figure 4b , the growth phenotypes of transgenic and wild-type (WT) plants in the phytotron were similar. In addition to the three aforementioned transgenic lines, parallel transgenic lines (e.g. OE-T2 and OE-T13), as demonstrated by semi-quantitative RT-PCR, qRT-PCR and western blot analysis ( Figure S4b-d) , also showed a similar growth phenotype to WT plants. When (-tp)AaIPPI1 transgenic plants were transferred to the green house for the production of seeds, their growth phenotypes were similar to those of the WT ( Figure S4a ). In our investigation, empty vector and other artemisinin pathway gene (such as ADS and HDR) transgenic plants (Ma et al., 2015 (Ma et al., , 2017 were routinely generated as a control to assess the potential effects of different transgenes on plant growth and other features. A. annua HDR (AaHDR1) transgenic plants (Ma et al., 2017) were used as a control to evaluate the effects of the binary construct on AaIPPI1 expression and plant growth. As observed for OE-T15 and OE-T17 (Figure 4c ), the growth of AaHDR1 transgenic plants was similar to that of WT plants ( Figure S5a ). Quantitative RT-PCR analysis showed that the expression levels of AaIPPI1 in WT and AaHDR1 transgenic plants were similar, but significantly lower than in (-tp)AaIPPI1 transgenic (OE-T3, OE-T15 and OE-T17) plants ( Figure S5b ). These data demonstrate that the high AaIPPI1 expression level in OE-T1, -T2, -T13, -T15, -T17 and -T23 (Figures 4c, S4b,c and S5b) resulted from (-tp)AaIPPI1 overexpression.
GC-MS and LC-MS analyses of artemisinic acid, arteannuin B and artemisinin
GC-MS analysis was performed to identify and measure the levels of artemisinic acid and arteannuin B in transgenic and WT plants. Metabolites were ionized using electron ionization. Total ion chromatography showed that the peak size of artemisinic acid was greater in two transgenic lines, OE-T15 and OE-T17, than in WT plants (Figure 5a ). Based on a standard curve ( Figure S6 ), quantification . Overexpression of (-tp)AaIPPI1 is targeted to the cytosol. (a) The cassette of the (-tp) AaIPPI1/EGFP fusion construct was used to examine the protein localization, and confocal images showed the subcellular localization of (-tp)AaIPPI1-EGFP in the cytosol of the leaves of Nicotiana benthamiana. (b) T-DNA cassette of a binary construct in which a 2 9 35S promoter was used to overexpress (-tp)AaIPPI1 showed that the content of artemisinic acid in the OE-T15 and OE-T17 lines was approximately 1.3% (g g À1 , dw), which was slightly higher than that in WT plants (Figure 6a) . Total ion chromatography also showed that the peak size of arteannuin B was much greater in transgenic than in WT plants (Figure 5b ). Based on a standard curve ( Figure S6 ), quantification showed that the content of arteannuin B was 2.6-4.0% (g g À1 , dw) in three transgenic lines (OE-T1, OE-T15 and OE-T17), which was significantly higher than that in WT plants (Figure 6b ). The arteannuin B content in other transgenic plant lines, such as OE-T2 and OE-T13, was also increased ( Figure S4e) , with values within this range. LC-MS analysis was conducted to identify and measure artemisinin. The selected ion chromatography [M + 1] recorded at [283] + showed that the peak size of artemisinin was greater in transgenic than in WT plants ( Figure S7 ). Tandem MS analysis also showed that the abundance of the MS/MS fragment was greater in transgenic than in WT plants ( Figure S8 ). Based on an artemisinin standard curve ( Figure S6 ), the calculation showed that the content of artemisinin was 0.17-0.26% (g g
À1
, dw) in the three transgenic lines, OE-T1, OE-T15 and OE-T17, which was two-to threefold higher than that in the WT plants (Figure 6b) . Quantification of artemisinin also demonstrated the increase in artemisinin contents ( Figure S4d ) in the two other transgenic lines (OE-T2 and OE-T13) that were grown in a green house ( Figure S4a ).
Decrease in isoprene formation in transgenic plants
Isoprene is directly biosynthesized from DMAPP (Figure 1a) . We used a fast isoprene sensor (FIS) to analyze isoprene emission from A. annua as described previously (Xi et al., 2016) . In FIS, isoprene is converted to photons, which are recorded by a computer. Multiple live recordings showed that not only the entire seedling but also the excised leaves emitted isoprene (Figure 6c ). At the beginning of the recording (defined as 0 s), when the samples were placed in a sealed chamber, no isoprene was detected. After a few or 10 s, FIS began to detect isoprene. When leaves of transgenic plants were placed in the chamber, the emission trend in the beginning was similar to that of WT samples (Figure 6c) . In comparison to the WT control samples, isoprene emission from the leaves and seedlings of transgenic lines, e.g. OE-T15 and OE-T17, was reduced (Figure 6c) . The average levels of isoprene emission per second over a 40-min period were calculated. The resulting data show that the emission of isoprene from leaves of OE-T15 and OE-T17 plants was significantly reduced (Figure 6d ).
DISCUSSION
Increasing artemisinin production is one of the global efforts in the fight against malaria. The transgenic plants developed in this study have the potential to provide arteannuin B as an alternative precursor for the semisynthesis of artemisinin in the future. Both chemical synthesis and bioconversion have been used to convert arteannuin B to artemisinin (Nair and Basile, 1993; Nowak and Lansbury, 1998) . Nair and Basile (1993) observed that under optimized buffer conditions, a crude enzyme extract could convert 80% of arteannuin B to artemisinin. This conversion rate is much higher than 40-45%, the rate obtained by the pharmaceutical industry to convert artemisinic acid to artemisinin (Paddon et al., 2013) . To date, however, arteannuin B has not been used as a precursor for the semi-synthesis of artemisinin, which can be explained by two scenarios inferred from previous studies. One explanation is likely to be associated with economic infeasibility, although the total synthesis of arteannuin B in the laboratory has been reported (Lansbury and Mojica, 1986) ; the other is the low production of arteannuin B in plants. Nair and Basile (1993) were able to extract only 23 mg of arteannuin B from 1 kg of dry leaves, representing approximately 0.0023% (g g À1 , dw). Woerdenbag et al.
reported the presence of approximately 0.1% (g g
À1
, dw) arteannuin B in leaves, flowers and young stems (Woerdenbag et al., 1991) , and 0.08% arteannuin B in a variety that is highly productive for artemisinin (Woerdenbag et al., 1994) . These studies show that it is not economically feasible to isolate arteannuin B for industrial-scale artemisinin semi-synthesis. Therefore to use arteannuin B as an alternative precursor source, increasing its production is necessary. We recently observed that the arteannuin B content in the above-ground tissues of our self-pollinated A. annua plants range from 0.7 to 1.3% (g g À1 , dw) during different developmental stages. In addition, the level of arteannuin B is not obviously affected by plant development from the early young seedling stages to the late flowering stage (Ma et al., 2015) . Furthermore, this property is also consistent in the progeny. Therefore, self-pollinated plants provide an appropriate platform for metabolic engineering to produce a high yield of arteannuin B. In the present study, the leaves of 7-week-old seedlings of transgenic plants (Figure 4b ) showed a significant increase in arteannuin B content compared with WT plants, and two lines, OE-T15 and OE-T17, produced approximately 4% (g g
, dw) arteannuin B (Figure 6a ). This high level of production suggests that transgenic plants may provide a viable resource for the extraction of arteannuin B in the future. In addition, the contents of artemisinic acid were increased in these two lines (Figures 5a and 6a) . Certainly, different transgenic effects on artemisinic acid contents were observed in multiple transgenic lines. For example, unlike in OE-T15 and OE-T17 lines, the artemisinic acid content was not significantly increased in line OE-T1 (Figures 5a and 6a ). This result was likely to be associated with the lower protein level in OE-T1 compared with OE-T15 and OE-T17 ( Figure S2d ).
The high production of arteannuin B and the increased levels of artemisinin that resulted from the increase in AaIPPI1 levels in the cytosol of transgenic plants described herein are related to the reduction of isoprene levels. IPPI catalyzes the interconversion of IPP and DMAPP, the C 5 building blocks of all short-and long-chain terpenoids, including monoterpenoids, sesquiterpenoids, diterpenoids, steroids and cholesterols (Figure 1a Zhou et al., 2013; Rodriguez-Concepcion and Boronat, 2015) . DMAPP is the primary starter molecule to which IPP is linked by prenyltransferases to form short-and long-chain isoprenoids, e.g. sesquiterpenoids resulting from the condensation of two IPP and one DMAPP. Our in vitro experiments showed that (-tp)AaIPPI1 isomerized IPP and DMAPP at a final ratio of approximately 1:7 at steady-state equilibrium. Based on this property of the enzymatic reaction, it can be hypothesized that the overexpression of (-tp)AaIPPI1 increases the content of DMAPP available for artemisinin biosynthesis in the cytosol. This hypothesis is supported by the observation that the transgenic plants displayed a highly increased production of arteannuin B and enhanced artemisinin content (Figure 6a, b) . This result actually raises an important question: if more IPP molecules are isomerized to DMAPP, leading to the increased production of arteannuin B and artemisinin in the cytosol, what is the source of the the additional IPP? Based on the literature reported for multiple plant species, IPP can be transported from plastids to the cytosol (Figure 1a ; Vranova et al., 2013) . Accordingly, it can be hypothesized that an increase in the transport of IPP from plastids to the cytosol may lead to a reduction of DMAPP levels in plastids. To investigate this possibility, we performed an FIS analysis. The resulting FIS data show that the emission of isoprene by transgenic plants was reduced (Figure 6c,  d ). Given that isoprene is the direct product of DMAPP in plastids (Figure 1a) , the results of the FIS analysis indicated a reduction in the levels of this substrate. This result is supported by our recent study of a synthetic plant-insect geranyl pyrophosphate synthase (GPPS) that condenses IPP and DMAPP to downstream terpenoid molecules (Figure 1a) . When the synthetic GPPS was overexpressed in the cytosol, the transgenic Camelina plants showed a significant decrease in isoprene emission and an increase in triterpenes, and enhanced plant growth (Xi et al., 2016) , suggesting that the transport of IPP from the plastids to the cytosol was increased. Our results also suggest that overexpression of AaIPPI1 in the cytosol may be useful for improving the production of artemisinin in other A. annua varieties. Genetic breeding studies have shown that there are two chemotypes of A. annua: those with high artemisinin production (HAP) and those with low artemisinin production (LAP) (Ting et al., 2013) . Our self-pollinated plants belong to the LAP chemotype. Based on the data reported herein, it is likely that the overexpression of (-tp)AaIPPI1 in HAP plants would greatly increase artemisinin levels.
Numerous studies have demonstrated a significant role of glandular trichomes in the biosynthesis of artemisinin (Duke and Paul, 1993; Duke et al., 1994; Tellez et al., 1999; Lommen et al., 2005; Teoh et al., 2006; Covello et al., 2007; Xiao et al., 2016) . A recent study reported that an increase in the number of trichomes significantly enhanced artemisinin production (Singh et al., 2016) . ADS, CYP71AV1, CPR1, DBR2, CYB5, ADH1 and ALDH1 ( Figure 1a) were originally identified in glandular trichomes (Bouwmeester et al., 1999; Ro et al., 2006; Weathers et al., 2006; Zhang et al., 2008 Zhang et al., , 2009 Teoh et al., 2009; Paddon et al., 2013) . In our study, we also isolated AaIPPI1 from glandular trichomes. RT-PCR analysis showed that glandular trichomes had the highest levels of AaIPPI1 transcription, although it was also highly expressed in other tissues (Figure 2a, b) . These data suggest that AaIPPI1 activity may be preferentially associated with the biosynthesis of artemisinin, arteannuin B and artemisinic acid in glandular trichomes. To date, numerous studies including ours have indicated that the engineering of trichomes may offer a promising approach to the improvement of the artemisinin yield for the fight against malaria.
EXPERIMENTAL PROCEDURES Plant materials and growth conditions
Two different ecotypes of A. annua were used in this study. One, collected from Sichuan Province, China, was named strain #001. This strain is a heterozygous variety that has been grown in green house for leaf materials (Chen et al., 2000; Han et al., 2006) . It was used to clone the AaIPPI1 gene. The other strain is a novel selfpollinated A. annua variety (Alejos-Gonzalez et al., 2011; Ma et al., 2015) . The progeny of the self-pollinated plants were grown in a phytotron for seeds, as reported previously (Alejos-Gonzalez et al., 2011). F 3 progeny seedlings grown in the phytotron were used for genetic transformation and functional analysis of AaIPPI1. The photoperiod and temperature used in the phytotron were 16/8 (h) and 25°C (Appendix S1). Leaves from plant nodes 7-12 ( Figure 4b ) were harvested and pooled for gene expression and metabolite analyses (Table S2) .
Isolation of AaIPPI1 cDNA
An EST cDNA library was constructed from glandular secretory trichomes of strain #001 (Appendix S1; Ma et al., 2009) . A cDNA sequence that was highly homologous to that of the isopentenyl diphosphate isomerase gene was identified from the library. Its full-length cDNA was obtained by RACE RT-PCR, as reported previously (Ma et al., 2009) ; it is denoted herein as AaIPPI1. Sequence alignment was completed using CLUSTALW at EMBnet (http://www.c h.embnet.org/software/ClustalW.html).
Heterogeneous expression of AaIPPI1 and purification of recombinant protein
The ORF of AaIPPI1 was amplified for heterogeneous expression using a pair of gene-specific primers, 5 0 -GATGGATCCATGGCA-GAAACGTTGGTCTCA-3 0 (forward primer, BamHI restriction site underlined) and 5 0 -GTACTCGAGTTACAAGTTATGGATTGTCTT-3 0 (reverse primer, XhoI restriction site underlined). The amplified cDNA fragment was digested with BamHI and XhoI, ligated to a pET-30a(+) vector that had also been digested with BamHI and XhoI (Novagen, now Merck Millipore, http://www.merckmillipore.c om), and then purified. The resulting plasmid, pET-(tp)AaIPPI1 ( Figure S2a ), could express a His-tag recombinant protein. In addition, an N-terminal truncated fragment of the AaIPPI1 cDNA was amplified using another primer pair: forward 5 0 -GATGGATCCAT-GACGACAATCTTGACTGAT-3 0 and reverse 5 0 -GTACTCGAGTTA-CAAGTTATGGATTGTCTT-3 0 , which contained BamHI and XhoI restriction sites (underlined), respectively. The resulting cDNA lacked the first 177 nucleotides of the ORF. This cDNA was ligated to pET30a(+) to generate pET-(-tp)AaIPPI1 ( Figure S2a) . The pET-(tp)AaIPPI1 and pET(-tp)AaIPPI1 plasmids were separately transformed into competent cells of E. coli strain BL21 (DE3). Two BL21 (DE3) colonies, one containing the pET-(tp)AaIPPI1 plasmid and the other containing the pET-(-tp)AaIPPI1 plasmid, were selected for protein expression. E. coli cells containing pET-(tp)AaIPPI1 or pET-(-tp)AaIPPI1 were cultured in liquid LB medium supplied with 50 mg L À1 ampicillin at 37°C. When the OD value of the suspension culture was approximately 0.6 at 600 nm, isopropyl-b-D-thiogalactopyranoside (IPTG) was added to the culture to a final concentration of 0.2 mM. The suspension culture was then incubated for an additional 6 h at 28°C. The cells were harvested by centrifugation and re-suspended in 10 ml of 0.05 M sodium phosphate buffer (pH 7.5) containing 20 mM imidazole; the suspension was sonicated on ice for 5 min at 50% pulses using an Ultrasonic Crasher. The homogenate was centrifuged for 10 min at 10 000 g at 4°C. The soluble crude protein was loaded onto an Ni-NTA His-Bind ™ Resin column (Novagen, now Merck Millipore) to purify the recombinant (-tp)AaIPPI1 according to the manufacturer's protocol. The column was washed with 0.05 M sodium phosphate buffer (pH 7.5) containing 20 mM imidazole to remove untargeted proteins. Then, the washed column was eluted with 2.5 ml of 0.05 M sodium phosphate buffer (pH 7.5) containing 300 mM imidazole to collect the recombinant protein. The resulting recombinant (-tp)AaIPPI1 was loaded onto PD-10 columns (Amersham Pharmacia Biotech, now GE Healthcare Life Sciences, http://www.gelifesciences.com) to further remove salt. The recombinant (-tp)AaIPPI1 was eluted from the PD-10 column in 0.1 M Tris-HCl (pH 7.5) containing 10% (v/v) glycerol and stored at À80°C. SDS-PAGE (10%) was used to assess the quality of purification. The protein concentration was determined by the Bradford method based on a standard curve of bovine serum albumin.
Enzyme assays
Enzyme assays were carried out in a 100-ll volumes consisting of 10 lg of recombinant (-tp)AaIPPI1, 100 mM Tris-HCl buffer (pH 7.5), 5 mM MgCl 2 , 10 mM DTT and 20 lg IPP or DMAPP in a 1.5-ml Eppendorf tube. In addition, 10 and 40 lg IPP or DMAPP was used to characterize the isomerization activity of recombinant (-tp) AaIPPI1. Different reaction times from 0.5 to 3 h were tested to optimize the reaction assays to characterize the isomerization properties. A duration of 3 h was found to be appropriate for the enzyme assay to characterize the steady-state ratio of IPP and DMAPP. After 3 h of incubation at 37°C, alkaline phosphatase (1 U) was added, and the incubation mixture was gently vortexed. The mixtures were incubated for an additional 3 h at 37°C to allow the enzyme to remove diphosphate from IPP and DMAPP, and to form their corresponding isoprenol and 3-methyl-2-buten-1-ol. After dephosphorylation, 200 ll of diethyl ether was quickly added to each tube, followed by six periods of rapid and thorough shaking to extract metabolites. The tubes were centrifuged for 5 min at 10 000 g, and the supernatants were pipetted into new tubes for the analysis of metabolites using GC-MS as described below, and for GC analyses on an HP-GCD instrument (Agilent, https://www.agilent.com). The metabolites were separated using a DB-5 silicon capillary column (30 m 9 0.25 mm; Agilent). Helium was used as the carrier gas at a flow rate of 1 ml min
À1
. A splitless mode was used in the inlet. The injection temperature was set to 250°C. The initial oven temperature was set to 40°C for 3 min; the temperature was then ramped to 250°C at a rate of 5°C per min. A positive electron ionization mode was used to characterize the enzymatic products. The mass detector was set to scan the mass range from 40 to 240 m/z.
In addition, dephosphorylation using hydrochloric acid was performed to characterize the isomerization catalyzed by AaIPPI1. For this assay, 20-and 40-lg substrates were used in the 2-h reaction incubation. All other reaction conditions were the same as those described above. After the reaction, the enzymatic products were dephosphorylated for 30 min with alkaline phosphatase (1 U) and then for 40 min with 1 N hydrochloric acid to analyze the ratios of isoprenol to 3-methyl-2-buten-1-ol. After dephosphorylation, 200 ll of diethyl ether was quickly added to each tube, which was then was rapidly and thoroughly shaken six times to extract metabolites. To separate the metabolites, the GC-MS instrument and oven temperature programmes differed from those described above. GC-MS analysis was performed using a GCQqQ MS (7890a-5975b, using an HP-5 ms column, 30 m 9 0.25 mm 9 0.10 lm; Agilent). The initial oven temperature was set to 35°C for 2 min and then ramped to 40°C for 5 min, followed by ramping to 325°C at a rate of 70°C per min and maintenance for 3 min. All other instrumental conditions were the same as those described above.
Transient expression of (-tp)AaIPPI1 in N. benthamiana
The stop codon TAA was removed from the truncated (-tp)IPPI cDNA fragment. The resulting cDNA fragment was fused upstream of and adjacent to the starter codon ATG of GFP in the binary vector pSITEII-EGFP-N1, using the gateway technique described below. The resulting new binary vector, pSITEII-(-tp) AaIPPI1-EGFP (Figure 4a ), was obtained for the protein localization assays. The vector was introduced into Agrobacterium tumefaciens strain LBA4404. A positive colony was used to infect N. benthamiana leaves according to an agroinfiltration protocol (Martin et al., 2009) . After 48 h, the infected leaves were examined for the green fluorescence of GFP using an LSM 5 PASCAL confocal laser scanning microscope (Carl Zeiss, https://www.zeiss.com).
Development of plant expression vectors and transformation of Agrobacterium tumefaciens
A gateway technique was used to construct binary vectors for gene expression in plants. The truncated cDNA (-tp)IPPI fragment containing the stop codon was cloned into an entry vector, pENTR/D-TOPO (Invitrogen, now ThermoFisher Scientific, https://www.ther mofisher.com), to obtain a pENTR-(-tp)AaIPPI1 plasmid. The destination vector used herein was PMDC84, which contains a 2 9 35S promoter and a GFP reporter gene (Curtis and Grossniklaus, 2003) . The pENTR-(-tp)AaIPPI1 and PMDC-84 plasmids were digested using LR Clonase II enzyme mix (Invitrogen), and ligated according to the manufacturer's protocol. After the ligation reaction, a new binary vector, PMDC84-(-tp)AaIPPI1 (Figure 4b ), was obtained in which the (-tp)AaIPPI1 cDNA fragment was inserted immediately downstream of the 2 9 35S promoter, but was not fused to GFP. The resulting PMDC84-(-tp)AaIPPI1 was used to express transgenic protein in the cytosol of plant cells. By following the protocol described previously (Xie et al., 2004) , this binary vector was introduced into Agrobacterium tumefaciens strain LBA4404 for the genetic transformation of A. annua, as described below. Seeds of the F 3 progeny of self-pollinating plants were sterilized and then germinated on agar-solidified MS basal medium (Murashige and Skoog, 1962) . The preparation and activation of LBA4404 harboring the PMDC84-(-tp)AaIPPI1 vector was performed as described previously (Xie et al., 2004) . In brief, leaves at the fifth, sixth and seventh nodes of 1-month-old seedlings were used as explants for infection by activated LBA4404. The infected leaf discs were inoculated on an agar-solidified selection medium, which was composed of MS basal medium supplemented with 1.0 mg L À1 N 6 -benzyladenine (BAP), 0.05 mg L À1 naphthalene-1-acetic acid (NAA), 20 mg L À1 hygromycin and 200 mg L À1 timentin. Selected leaf discs were transferred to newly prepared selection medium every 10 days. After approximately 45 days of selection, multiple hygromycin-resistant adventitious shoots were formed from calli induced from those infected leaf discs. Resistant shoots with three or four leaves were excised from the calli and inoculated on an optimized rooting medium (Alejos-Gonzalez et al., 2013) , consisting of half-strength MS basal medium supplemented with 0.5 mg L À1 NAA, 20 mg L À1 hygromycin and 200 mg L À1 timentin. After 1-2 weeks of root induction, hygromycin-resistant plantlets were obtained and then planted in potting soil as described previously (Alejos-Gonzalez et al., 2013) . In addition, the same binary vector has been used to overexpress other artemisinin pathway genes (such as AaHDR1) in A. annua (Ma et al., 2017) . AaHDR1 transgenic plants ( Figure S5a ) were used as a control to assess whether or not the binary vector used alone could affect AaIPPI1 expression.
Semi-quantitative RT-PCR, real-time quantitative RT-PCR and western-blot analysis
Total RNA was isolated from young leaves of transgenic candidates and WT plants using an RNeasy Plant Mini Kit (Qiagen, https://www.qiagen.com). All total RNA samples were treated with on-column DNase treatment (Qiagen) to remove genomic DNA, as reported previously (Shi and Xie, 2010) . The first-strand cDNA was synthesized using 1.0 lg of DNA-free RNA using PowerScript reverse transcriptase (RT; Clontech, https://www.clontech.com). One microliter of cDNA was used as a template for PCR with Taq polymerase (Promega, https://www.promega.com). These three types of experiments were performed according to the protocols of the three manufacturers. RT-PCR was performed for the (-tp) AaIPPI1 transgene and two positive controls, an HMG-CoA reductase gene (HMGR) and a farnesyl pyrophosphate synthase gene (FPS). In addition, the housekeeping gene b-actin was used as a reference control. The gene-specific primers and PCR thermal cycles used for these genes are presented in Table S1 .
For the quantitative analysis, real-time qPCR was performed with Power SYBR Green PCR Master Mix (Applied Biosystems, now ThermoFisher Scientific, https://www.thermofisher.com), according to the manufacturer's guidelines. The thermal cycles were composed of 50°C for 2 min and 95°C for 10 min, followed by 45 cycles of 95°C for 15 s and 60°C for 1 min, and then 40°C. Five replicates and three replicates were evaluated for AaIPPI11 and ACTIN, respectively. ACTIN was used as an internal standard for normalization. The relative expression of AaIPPI1 was calculated using the DDC t algorithm.
Based on the AaIPPI1 amino acid sequence, an oligomeric peptide consisting of CKAPSDGKWGEHELD was synthesized by GEN-SCRIPT (http://www.genscript.com). This oligomeric peptide, which was optimized to exclude the conserved domains of this enzyme family using the Antigen Design Tool, was used for the production of polyclonal antibodies. The resulting antibodies were used to specifically analyze the expression of the (-tp)AaIPPI1 protein in plants. Total crude protein extraction and immunoblot analyses were performed according to a previously reported method for deoxy-D-xylulose-5-phosphate synthase (Munoz-Bertomeu et al., 2006) . Briefly, total protein was extracted from the leaves of transgenic A. annua and WT plants. Crude protein samples were separated by SDS-PAGE, transferred to nitrocellulose membranes, and probed with rabbit anti-AaIPPI1 antibodies. An anti-rabbit IgG HPR conjugate was used as a secondary antibody (Promega). A SuperSignal West Pico Trial Kit (ThermoFisher Scientific, https:// www.thermofisher.com) was used to detect the immunoblotting signal on X-ray film according to the manufacturer's protocol.
Extraction of metabolites and GC-MS analysis
Based on our previous approaches to the metabolomic characterization of the landscape of isoprenoids in A. annua (Ma et al., 2015) , hexane was used to extract non-polar metabolites, and GC-MS analysis was performed using a gas chromatograph 6890 coupled with 5975C MSD (Agilent Technologies, https://www.agilent.com; Ma et al., 2015) . An RTX-5 capillary column (30 m 9 0.25 mm 9 0.25 lm) was used to separate metabolites. A splitless mode was used in the inlet. The injection temperature was set to 250°C. The oven temperature was initially set at 60°C and then ramped to 260°C at a constant rate of 10°C min À1 and held at 260°C for 25 min. Pure helium was used as the carrier gas at a flow rate of 1 ml min À1 . A positive electron impact ion source (70 eV) was used to ionize compounds, and mass fragments were scanned in the range of 40-800 (m/z), with a 4-min solvent delay. Ion chromatographic peaks detected by GC-MS were deconvoluted using Agilent MassHunter Mass Profiler (MHMP) and Mass Profiler Professional (MPP) software, as described previously (Ma et al., 2015) . An authentic standard of arteannuin B (ALB-RS-0427; ALB Technology Limited, https://www.albtechnology.com) was used to establish a standard curve ( Figure S6 ) to quantify this metabolite in plants. In addition, authentic standards of artemisinic acid and artemisinin (purchased from Sigma-Aldrich, https://www.sigmaald rich.com) were used to establish standard curves ( Figure S6 ).
HPLC-MS and LC-Q-TOF-MS/MS analysis of artemisinin
Artemisinin extraction and quantification using HPLC-MS analysis on a 2010-eV LC/UV/ESI/MS instrument (Shimadzu, http://www.shi madzu.com) were performed as described previously (Alejos- Gonzalez et al., 2011 Gonzalez et al., , 2013 . Artemisinin was further analyzed using LC-Q-TOF-MS/MS on an Agilent 6520 Q Time-of-Flight Tandem Mass Spectrometer coupled with an HPLC 1200 instrument (Agilent Technologies). The method used in this study has been reported recently (He et al., 2016) .
Analysis of isoprene using the fast isoprene sensor
The fast isoprene sensor (FIS; Guenther and Hills, 1998; Exton et al., 2010) has been developed to specifically measure isoprene emission in our laboratory (Xi et al., 2016) . In this study, WT, OE-T15 and OE-T17 plants ( Figure 4b ) were used to measure isoprene. The measurements were conducted using the leaves of 7-week-old plants (Figure 4b ) according to the protocol developed by our group (Xi et al., 2016) . Briefly, three leaves were excised from plants as a biological sample and placed in a sealed chamber connected to the FIS (Hills Scientific, http://www.hills-scientific.c om). After the FIS was calibrated using an isoprene standard, a continuous recording was performed for 40 min to characterize the isoprene emissions. All measurements were performed between 09:00 and 15:00 h at 25°C under a 16-h photoperiod, supplemented with 50 lmol m À2 s À1 light intensity. To reduce the potential effects of measurement time on isoprene emission, the following steps were developed: the first measurement was performed using biological sample 1 in the order OE-T17, WT and OE-T15; the second measurement was performed using biological sample 2 in the order OE-T15, OE-T17 and WT; and the third measurement was performed using biological sample 3 in the order WT, OE-T15 and OE-T17. In FIS, isoprene is converted to photons in the presence of an ozone flow. The emitted photons were recorded every 5 s by a computer using FIS software. At the end of the experiment, the biological samples were carefully weighed to determine their fresh weights. The number of photons recorded over a 40-min period was averaged to estimate the mean value of isoprene emitted per gram of fresh tissue per second.
Statistical analysis
The Student's t-test was used to evaluate the statistical significance of differences in plant growth and in the levels of various metabolites. P values less than 0.05 were considered statistically significant.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article. Figure S1 . Alignment of the deduced amino acids of Artemisia annua isopentenyl diphosphate isomerase 1 and six homologs using CLUSTALW (Thompson et al. 1994) . Figure S2 . Recombinant protein expression in Escherichia coli for enzymatic assay and western blotting analysis of transgenic protein expression in plants. Figure S3 . Ion chromatograph showing isomerization of IPP and DMAPP catalyzed by recombinant (-tp)AaIPPI1 and dephosphorylated by alkaline phosphatase or alkaline phosphatase and 1 N hydrochloric acid (HCl). Figure S4 . Overexpression of (-tp)AaIPPI1 targeted to the cytosol increases artemisinin content. Figure S5 . Expression comparison of AaIPPI1 in wild-type, AaIPPPI1 overexpression and control (AaHDR1) transgenic plants. Figure S6 . Standard curves established using arteannuin B, artemisinic acid and artemisinin for the quantification of the three compounds from plants. Figure S7 . Selected ion chromatograms of [283] + from the HPLC-MS analysis showing higher levels of artemisinin in the leaves of OE-T17 plants in comparison to wild-type plants. Figure S8 . Tandem MS profiles of artemisinin. Artemisinin from transgenic plants, wild-type plants and authentic standard samples were analyzed using tandem MS on an LC-Q-TOF-MS/MS instrument. Table S1 . Primer pairs designed for RT-PCR and thermal cycle programs for cDNA amplification. Table S2 . Sampling for analysis of arteannuin B, artemisinin and artemisinic acid, RNA isolation, and protein extraction. Appendix S1. Plant growth in the phytotron and sampling; isolation of glandular trichomes.
